ERA

ERA 2023 – longer is stronger for Vera
EP Vantage
Tue, 06/20/23 - 09:59 am
ERA
Vera Therapeutics
IgAN
atacicept
immunoglobulin A nephropathy
After high-profile US rejection for roxadustat, Astellas touts its safety in new pooled analysis
Fierce Pharma
Thu, 05/19/22 - 10:32 am
Astellas
roxadustat
FibroGen
ERA
erythropoietin